Medical devices, healthcare technology and the business of care
PMA approval · P180036

OPTIMIZER Smart System

Impulse Dynamics (Usa), Inc. · Decision date Mar 21, 2019

MEDTECHLEDGER EXPLANATIONP180036

What did the FDA approve?

FDA approved the OPTIMIZER Smart System under PMA P180036 on March 21, 2019. The implantable pulse generator delivers Cardiac Contractility Modulation therapy and is indicated to improve 6-minute hall walk distance, quality of life, and functional status of NYHA Class III heart failure patients who remain symptomatic despite guideline directed medical therapy, who are in normal sinus rhythm, are not indicated for Cardiac Resynchronization Therapy, and have a left ventricular ejection fraction ranging from 25% to 45%.

The applicant is Impulse Dynamics (Usa), Inc., and the product code is QFV under the cardiovascular specialty. The decision record does not include supplement type or supplement reason fields, so no information is present about whether this entry reflects an original approval or a later change to an existing PMA.

FDA approval order statement

Approval for the OPTIMIZER Smart System. The device which delivers Cardiac Contractility Modulation therapy, is indicated to improve 6-minute hall walk distance, quality of life, and functional status of NYHA Class III heart failure patients who remain symptomatic despite guideline directed medical therapy, who are in normal sinus rhythm, are not indicated for Cardiac Resynchronization Therapy, and have a left ventricular ejection fraction ranging from 25% to 45%.
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Mar 21, 2019

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P180036
Regulatory pathway
Premarket approval application
Product code
QFV
Decision code
APPR
Decision date
Mar 21, 2019
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implantable pulse generator.

Product code
QFV
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P180036 received

    Application receipt date recorded by FDA.

  2. P180036 · FDA decision

    APPR

  3. P180036/S046 · Related supplement

    OPTIMIZER Smart and Smart Mini System

Timeline entries are records held by MedtechLedger for P180036. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P180036

Product / regulatory recordCompanyPathwayDecision dateSource
Impulse Dynamics (Usa), Inc.PMA supplementSep 24, 2026FDA
Impulse Dynamics (Usa), Inc.PMA supplementOct 14, 2026FDA

Explore the linked device profile

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Impulse Dynamics (Usa), Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
50 Lake Center Executive Pkwy., 401 Rte. 73 N, Bldg. 50 Suite 100, Marlton, NJ, 08053

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records